Former U.S. Rep. Jennifer Wexton uses AI-generated voice tech to address PSP symptoms, advocates for Parkinson's legislation, impacting healthcare innovation and insurance compliance.
CCS’s AI-driven PropheSee™ platform significantly improves CGM adherence in Medicare diabetes patients, saving $10M+ and advancing preventive chronic care.
Explore the 2024 CMS prior authorization rule and the impact of AI on healthcare administrative processes, improving compliance and patient care timelines.
Explore the impact of Medicare Administrative Contractors on coverage decisions for advanced wound care therapies and the potential of AI-driven reforms to improve patient access and reduce costs.
Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.
Reveleer acquires Novillus to enhance its AI-driven value-based care platform, improving payer-provider collaboration, care gap closure, and clinical intelligence for health plans.
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
